HLB Therapeutics Co.,Ltd. (KOSDAQ:115450)
South Korea · Delayed Price · Currency is KRW 3,335.00
-60.00 (-1.77%)
Oct 31, 2025, 3:30 PM KST
HLB Therapeutics Market Cap
HLB Therapeutics has a market cap or net worth of 280.06 billion as of October 31, 2025. Its market cap has decreased by -62.78% in one year.
Market Cap
280.06B
Enterprise Value
310.81B
Revenue
61.23B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,335.00
Market Cap Chart
Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 280.06B, an increase of 164.70%. That is a compound annual growth rate of 6.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 280.06B | -70.03% |
| Dec 30, 2024 | 934.49B | 182.02% |
| Dec 28, 2023 | 331.36B | -9.25% |
| Dec 29, 2022 | 365.14B | -3.64% |
| Dec 30, 2021 | 378.91B | -51.22% |
| Dec 30, 2020 | 776.71B | 0.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 87.69T |
| Celltrion | 39.50T |
| ALTEOGEN | 25.46T |
| SK Biopharmaceuticals | 9.08T |
| Yuhan | 8.94T |
| HLB Co., Ltd. | 6.25T |
| Peptron | 6.06T |
| PharmaResearch | 5.57T |